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Abstract
The exposure to respirable crystalline silica (RCS), e.g. quartz, in industrial settings can induce sili-
cosis and may cause tumours in chronic periods. Consequently, RCS in the form of quartz and cris-
tobalite has been classified as human lung carcinogen category 1 by the International Agency for 
Research on Cancer in 1997, acknowledging differences in hazardous potential depending on source 
as well as chemical, thermal, and mechanical history. The physico-chemical determinants of quartz 
toxicity are well understood and are linked to density and abundance of surface silanol groups/radi-
cals. Hence, poly-2-vinylpyridine-N-oxide and aluminium lactate, which effectively block highly reac-
tive silanol groups at the quartz surface, have formerly been introduced as therapeutic approaches in 
the occupational field. In the traditional ceramics industry, quartz-containing raw materials are indis-
pensable for the manufacturing process, and workers are potentially at risk of developing quartz-
related lung diseases. Therefore, in the present study, two organosilanes, i.e. Dynasylan® PTMO and 
Dynasylan® SIVO 160, were tested as preventive, covalent quartz-coating agents to render ceramics 
production safer without loss in product quality. Coating effectiveness and coating stability (up to 1 
week) in artificial alveolar and lysosomal fluids were first analysed in vitro, using the industrially rel-
evant quartz Q1 as RCS model, quartz DQ12 as a positive control, primary rat alveolar macrophages 
as cellular model system (75 µg cm−2; 4 h of incubation ± aluminium lactate to verify quartz-related 
effects), and lactate dehydrogenase release and DNA strand break induction (alkaline comet assay) 
as biological endpoints. In vitro results with coated quartz were confirmed in a 90-day intratracheal 
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instillation study in rats with inflammatory parameters as most relevant readouts. The results of the 
present study indicate that in particular Dynasylan® SIVO 160 (0.2% w/w of quartz) was able to effec-
tively and stably block toxicity of biologically active quartz species without interfering with technical 
process quality of certain ceramic products. In conclusion, covalent organosilane coatings of quartz 
might represent a promising strategy to increase workers’ safety in the traditional ceramics industry.
Keywords:  coating of quartz; organosilane; quartz toxicity; rat alveolar macrophages; respirable crystalline silica; 
silanol groups; silicosis; traditional ceramics industry
Introduction
Prolonged exposure to respirable crystalline silica (RCS) 
can induce silicosis and may cause lung tumours in 
chronic periods. In 1997, the International Agency for 
Research on Cancer (IARC) therefore classified RCS, in 
the form of quartz or cristobalite, as category 1 human 
carcinogen. But, differences in the hazardous potential of 
RCS were acknowledged, depending on its source (inher-
ent characteristics), chemical, thermal, and mechani-
cal history and the specific industrial scenario. Namely, 
certain external factors/events can lead to activation or 
passivation of biologically active RCS surfaces, resulting 
in ‘chemical agents’ with the same nominal composition 
(SiO2), but with radically opposed toxicities (Fubini, 
1998a, 1998b).
Schlipköter and Brockhaus (1961) postulated that 
silanol groups (Si-OH), abundant on the quartz surface 
and also generated mechanically and by hydrolysis of 
siloxane bridges (Si-O-Si) (Nolan et al., 1981), repre-
sent, besides surface radical formation (Fubini, 1998a, 
1998b), the main determinants of RCS-mediated patho-
logical effects. By using as-grown quartz crystals with 
intact surfaces, Turci et al. (2016) recently demonstrated 
that the biological activity of quartz thereby seems not 
be determined by silanol groups per se but that it needs 
conchoidal surface fractures and thus a disordered panel 
of silanols, siloxanes, and rings for quartz–cell mem-
brane interactions. But, it should in any case be possible 
to neutralize these active centres and to reduce silanol 
heterogeneity by strong adsorption of certain molecules 
such as aluminium salts, metal iron, proteins, or phos-
pholipids to prevent deleterious quartz–cell membrane 
interactions, which can result in formation of reactive 
oxygen species, membrane damage/haemolysis, cyto-
toxicity, DNA damage, cytokine release, and subse-
quently lung toxicity, inflammation, silicosis, and even 
tumour formation (Fubini, 1998a, 1998b; Schins et al., 
2002; Albrecht et al., 2004). Interestingly, clear correla-
tion between quartz-mediated haemolytic activity and 
inflammasome activation could be demonstrated by 
Pavan et al. (2014), pointing to the same physico-chemi-
cal structures as determinants.
Polyvinylpyridine-N-oxide (PVPNO) and aluminium 
salts have already been tested as non-covalent surface 
modifications to treat or prevent silicosis, however, 
with limited success (Weller, 1975; Zhao et al., 1983; 
Prügger et al., 1984; Bégin et al., 1986; Goldstein and 
Rendall, 1987; Dubois et al., 1988; Dufresne et al., 
1994; Bégin et al., 1995). PVPNO forms strong hydro-
gen bonds via NO− groups, thus masking negatively 
charged SiO− groups (reviewed by Castranova, 1995), 
whereas aluminium lactate (AL) can block surface 
charges and radical formation via the aluminium cat-
ion and related ionic forces (Bégin et al., 1986; Brown 
et al., 1989; Duffin et al., 2001; Albrecht et al., 2004, 
2007). AL seems to be less effective in vivo than PVPNO, 
perhaps because of different modes of action and differ-
ential modification of cell type-specific uptake and elimi-
nation of treated quartz by alveolar macrophages (AM) 
(Höhr et al., 2002; Albrecht et al., 2007, 2009). Irrespec-
tive of non-covalent binding, however, PVPNO was able 
to clearly reduce NLRP3 inflammasome activation by 
quartz DQ12 in the rat lung, using IL-1β and caspase-1 
immunostaining as readouts (Peeters et al., 2014). Unlike 
PVPNO and AL, organosilane compounds, which were 
already shown to attenuate quartz toxicity in vitro and 
in vivo (Wiessner et al., 1990; Vallyathan et al., 1992; 
Castranova et al., 1995), react chemically with Si-OH 
groups, leading to potentially more durable, covalent, 
thin quartz surface coatings.
Though the research line on passivation of reactive 
quartz surfaces was already started in 1960, mainly for 
therapeutic purposes (Weller, 1975; Zhao et al., 1983; 
Prügger et al., 1984; Dubois et al., 1988), none of the 
mentioned coating agents appear to have been used so 
far preventively on an industrial scale to increase work-
ers’ safety. Only Vallyathan et al. (1991) proposed to 
incorporate organsilanes into water sprays of drill bits. 
To close this gap, the EU-funded project SILICOAT was 
set up, which aimed at increasing workers’ safety in the 
traditional ceramics’ industry (tiles, tableware, sanitary 
ware) by developing and implementing cost-effective, 
covalent RCS-coating technologies into ceramic pro-
cesses. RCS-containing materials are indispensable for 
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ceramics’ production, and many workers are thus poten-
tially at risk. The coatings should stably saturate reactive 
surface Si-OH groups and inhibit quartz-specific toxic-
ity, while maintaining product quality.
As an integral part of the SILICOAT project, the 
present study primarily aimed at biologically analysing 
and proofing in vitro and in vivo quartz-coating effec-
tiveness and stability of two different organosilane-
based quartz coatings. Organosilanes are widely used 
industrially in treating/functionalizing siliceous (Plued-




The industrial quartz Q1, used in a sanitary ware com-
position, was selected as model quartz for the coating 
trials. Crystalline silica content (100% w/w) was deter-
mined by X-ray diffraction (Philips 1820/00 diffrac-
tometer, The Netherlands), particle size distribution 
(d10 = 1.9, d50 = 12.1, and d90 = 37.2 µm) by laser diffrac-
tion (Malvern Mastersizer 2000, UK), and surface area 
(0.87 m2 g−1) by the Brunauer–Emmett–Teller method 
(TriStar 3000, Micromeritics, USA).
Negative and positive controls
For both in vitro and in vivo experiments, highly active 
quartz, DQ12 midsize Dörentrup (87% α-quartz, 13% 
amorphous silica; geometric mean diameter, weighted 
by mass: 3.0 µm; Bergbauforschung, Essen, Germany), 
served as technical/methodological positive control for 
quartz-dependent biological effects. DQ12 is a very 
active and stable quartz dust, showing no aging effect 
(i.e. loss of toxic potency with time). It is the number 
1 quartz in a ranking list of the most active quartzes. 
Therefore, DQ12 has become the standard reference pos-
itive control quartz for experimental biology in Europe 
(Robock, 1973; Clouter et al., 2001; Creutzenberg 
et  al., 2008). Water-sized aluminium oxide (Al2O3; 
geometric mean diameter, weighted by mass: 4.1 µm), 
derived from fused, active, neutral Al2O3, type 507 C 
(Sigma–Aldrich, Taufkirchen, Germany) served as in 
vitro particulate negative control. Al2O3 was relatively 
inert in previous short-term assays with cultured rat AM 
(Ziemann et al., 2009, 2014a, b). As non-particulate in 
vitro and in vivo negative controls, cell culture medium 
and physiological saline (0.9%) were used, respectively.
Coating agents and quartz-coating procedures
As coating agents, two commercially available organosi-
lanes were selected with help of Evonik Degussa 
International AG (Essen, Germany), i.e. hydrophobic 
Dynasylan® PTMO [propyltrimethoxysilane (PTMO); 
Fig. 1] and hydrophilic Dynasylan® SIVO 160 (SIVO160; 
oligomeric, amino-modified siloxane), to have clearly 
varying technical options in the industrial implementation 
trials. For quartz coating, PTMO was first suspended in 
water. To accelerate initial hydrolysis 0.01 M hydrochloric 
acid was added (HCl:PTMO ratio by mass of 1:2.5). Liq-
uid was stirred until homogeneity, before Q1 was added 
and allowed to react with hydrolysed PTMO (0.1, 0.5, 
Figure 1. Hydrolysis of PTMO and coating reaction with reactive silanol groups on the quartz surface.
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or 1.4% w/w of quartz) under stirring for 3 h at room 
temperature. SIVO160-coated Q1 was prepared similarly, 
but without the hydrolysis step, as SIVO160 represents a 
stabilized, pre-hydrolysed suspension. SIVO160 (0.2, 0.4, 
or 1.0% w/w of quartz) was incubated with Q1 for 2 h. 
All quartz suspensions were finally filtered using Büchner 
flasks and then repeatedly washed with ethanol to remove 
any surplus of additive. Uncoated reference Q1 particles 
were treated equally, but without organosilane addition. 
The coating procedures were initially developed under 
laboratory-scale conditions, before being adapted to pro-
duction plant conditions.
Endotoxin content and sizing of particle fractions
To avoid biological test artefacts, endotoxin content of 
all investigated particles was initially determined, using 
the ‘limulus amebocyte lysate (LAL) assay’ (Lonza, 
Cologne, Germany), and was shown for all samples to 
be clearly below the detection limit or below 8 ng rat−1 
lung, as threshold for in vivo relevance (Elder et al., 
2000). Whereas in vitro experiments were performed 
with the bulk materials, water-sizing was done for in 
vivo use. For this, 2.5 or 2 × 2.5 g of bulk material were 
added to a ~10 cm water column (volume ~110 ml) in 
a glass container. After sedimentation for 15–35 min, 
90–95 ml of supernatant were freeze-dried using stain-
less steel dishes. Particle size distribution was checked 
by scanning electron microscopy. Geometric mean diam-
eters, weighted by mass, were 4.17 (Q1), 4.49 (0.5% 
PTMO), and 4.85 µm (0.2% SIVO160).
Cell isolation, cell culture, and particle treatment 
in vitro
Primary rat AM, as main regulators of inflammation 
and clearance in the lung, were used as in vitro model. 
AM were previously shown to be highly quartz-respon-
sive after in vitro exposure (Ziemann et al., 2009). AM 
were isolated from pathogen-free female Wistar rats 
[strain: Crl:WI(Han); Charles River, Sulzfeld, Germany] 
by bronchoalveolar lavage (BAL) with physiological 
saline. About 1.5–2 × 105 cells per well were plated in 
hydrophobic 24-well plates (NUNC, Wiesbaden, Ger-
many) and pre-cultured for 24 h, as described previously 
(Ziemann et al., 2014b). Twofold concentrated particle 
stock suspensions were prepared in cell culture medium 
without FCS and antibiotics by ultrasonication for 
5 min in a water bath. To avoid cell activation, particles 
were added to the cultures (final concentration: 75 µg 
cm−2) without medium exchange. AM were incubated 
for 4 h in the dark at 37°C and 5% CO2 in a humidified 
atmosphere. One of two parallel cultures additionally 
received 100 µM AL (Aldrich, Taufkirchen, Germany) to 
verify quartz-specific effects. The quartz-quenching effect 
of AL had previously been confirmed in AM (Monfort 
et al., 2008; Ziemann et al., 2009, 2014a). After incu-
bation, supernatants were taken for determination of 
lactate dehydrogenase (LDH) activity. For gentle cell 
detachment, needed for the alkaline comet assay, AM 
were then placed on ice for 10 min. For the LDH assay, 
a ‘background control’ (wells without cells, but with cul-
ture medium) and a ‘maximum control’ (cells treated for 
10 min with 1% Triton X-100 = maximum amount of 
releasable enzyme activity) were included.
LDH assay in vitro
LDH release/activity, indicating disturbance of cell 
membrane integrity, was chosen as in vitro cytotoxic-
ity endpoint. This endpoint had previously been used 
to compare different quartz-containing ceramic dusts in 
AM (Ziemann et al., 2009), and was additionally used 
in the present study as early in vivo biomarker in BAL 
fluid. LDH activity was determined in culture super-
natants using the ‘Cytotoxicity Detection Kit’ (Roche, 
Mannheim, Germany). Absorbance was measured in 
triplicate at 490 and 630 nm with an ELISA reader. Per-
cent LDH activity was finally calculated by subtracting 
the ‘background control’ absorbance value and setting 
the ‘maximum control’ value to 100%.
Alkaline comet assay in vitro
To detect direct DNA damage, the alkaline comet assay 
was used (Singh et al., 1988; Tice et al., 2000). This 
test had previously demonstrated good quartz DQ12 
responsiveness, with complete inhibition by parallel AL 
treatment (Ziemann et al., 2009, 2014a). Detailed meth-
odology had been described previously (Ziemann et al., 
2014b). All methodological steps following cell detach-
ment were done under red light to avoid unspecific DNA 
damage. Coded slides were semi-automatically analysed 
using an Axioskop fluorescence microscope (Zeiss, Göttin-
gen, Germany) and the Comet Assay III software (Percep-
tive Instruments, Bury St. Edmunds, UK). Tail intensities 
(TI) of 100 nuclei were determined per slide/treatment 
and experiment, precluding so-called ‘hedgehogs’ or over-
lapping nuclei/comets from analysis. For every question, 
three independent experiments were performed. Means ± 
standard deviation (SD) were finally calculated from the 
mean TIs of the independent experiments.
Artificial physiological fluids and in vitro testing 
of coating stability
Coating stability of 0.5% PTMO-coated Q1, show-
ing the best in vitro results, was tested for up to 1 
week in both artificial alveolar fluid (AAF; pH 7.4) and 
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lysosomal fluid (ALF; pH 4.5; representing macrophages’ 
lysosomal ambience). AAF was prepared as described 
in detail by Kirkland et al. (2015). ALF preparation 
resembled that described by Hedberg et al. (2010), with 
slight modifications. Na2HPO4 content was 0.095 g l
−1, 
and 2.3 ml of a 16% (w/w) formaldehyde stock solu-
tion were added. For both AAF and ALF preparation 
HPLC grade, ultrapure water and salts of highest purity 
were used. For testing of coating stability 250 mg of Q1 
or 0.5% PTMO-coated Q1 were incubated in 40 ml of 
AAF or ALF in a drying chamber at 37°C for 24, 48, 
72, or 168 h. Tubes were rotated at low frequency to 
avoid sedimentation and to enable good particle wetting. 
After incubation, particles were washed 3× to remove 
free coating material. To this, samples were centrifuged 
(10 min, 1932 g), supernatant was discarded, and parti-
cles were resuspended in ultrapure water. After washing, 
samples were resuspended in 25 ml of water, transferred 
to glass staining tanks, and freeze-dried. As references 
(0 h), coated and uncoated Q1 samples, not incubated 
with AAF or ALF, but subjected to the whole washing 
and freeze-drying procedure were used to minimize dif-
ferences in sample activity from dissimilar handling. 
Finally, cytotoxicity and genotoxicity of the AAF- and 
ALF-treated samples were determined in vitro.
In vivo validation study
To finally investigate coating stability in vivo, a 90-day 
study with five treatment groups was set up: (i) physi-
ological saline, (ii) Q1, (iii) Q1 + 0.5% hydrolysed 
PTMO w/w of quartz, (iv) Q1 + 0.2% SIVO160 w/w 
of quartz, and (v) quartz DQ12. This study was per-
formed in compliance with the German Federal Act 
on the Protection of Animals (2013). Male Wistar rats 
[strain: Crl:WI(Han); Charles River] were randomized 
into groups of five animals. Animal age was ~7 weeks at 
delivery and ~9 weeks at treatment start. Particles (total 
dose 1 mg animal−1) were administered to the lungs 
by intratracheal instillation of two 0.5 mg aliquots in 
0.3 ml of physiological saline on consecutive days. To 
minimize particle agglomeration and assure homog-
enous distribution in the alveolar region, application 
suspensions were ultrasonicated and shaken moderately 
prior to instillation. On day 28 or 90 post-instillation, 
rats were sacrificed after anaesthesia with an overdose 
of pentobarbital sodium (Narcoren™) by cutting the 
vena cava caudalis. BAL was subsequently performed 
using the method of Henderson et al. (1987) with minor 
modifications. Lungs were lavaged twice with 5 ml of 
0.9% NaCl each. BAL fluid was collected in calibrated 
tubes on ice and harvested volumes were recorded. 
Study endpoints comprised body weights (before treat-
ment, at weekly intervals in the post-treatment obser-
vation period, terminally), terminal lung wet weights, 
and total leukocyte counts in the BAL fluid. Total leuko-
cytes were counted light microscopically using a Fuchs-
Rosenthal counting chamber (unit: cells per millilitre 
of lavagate). Differential cell counts were assessed by 
preparing two cytoslides (cytocentrifuge, Shandon Co., 
Frankfurt, Germany) and microscopically analysing 400 
leukocytes per rat regarding macrophage, polymorpho-
nuclear neutrophil (PMN; unspecific inflammation) and 
lymphocyte (specific inflammation) numbers. Results 
were given in absolute numbers per BAL fluid volume. 
After centrifugation of the BAL fluid, biochemical indi-
cators, relevant for diagnosis of lung damage, i.e. LDH 
release (membrane damage), β-glucuronidase activ-
ity (phagocytic activity and/or lysis of macrophages), 
and total protein levels (transudation and epithelial 
cell damage) were determined in supernatants. All bio-
chemical parameters were analysed according to routine 
clinical chemistry protocols using a Cobas Fara device 
(Roche Co., Grenzach, Germany).
Statistics
In the in vitro experiments, statistically significant differ-
ences from the particulate negative control were calcu-
lated by Student’s t-test for unpaired values (two tailed), 
whereas Student’s t-test for paired values (two tailed) 
was used to evaluate differences between uncoated and 
coated and between AL-untreated and AL-treated sam-
ples. The in vivo tests were statistically analysed using 
Dunnett’s test (treated groups versus negative control) 
and t-test for unpaired values (two-tailed, single treat-
ment groups versus control and uncoated versus coated 
quartz). Both in vitro and in vivo data were considered 
significant, if P ≤ 0.05. For statistical analyses, the Sigma 
Stat 3.1® software package (Systat Software, Inc., Point 
Richmond, CA, USA) was used.
Results
In vitro determination of coating efficiency— 
laboratory scale
Q1 was coated with hydrolysed PTMO or SIVO160 
under laboratory-scale conditions, using differ-
ent amounts of the coating agents. Both PTMO 
and SIVO160 concentration dependently quenched 
Q1-induced LDH release. Hydrolysed PTMO was most 
effective at 0.5 and 1.4% w/w of quartz. Complete inhi-
bition of LDH release by SIVO160 was noted at 0.2 and 
0.4% w/w (Figs 2A and C), whereas 1.0% SIVO160 
was substantially less potent. Both PTMO and SIVO160 
clearly reduced Q1-enhanced mean TI and thus direct 
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DNA damage. Nevertheless, slight quartz-dependent 
effect persisted, as determined by parallel AL incubation. 
DNA damage was maximally inhibited with the 0.5% 
PTMO (81% inhibition) and 0.2% SIVO160 (83% inhi-
bition) coatings, but did not reach statistical significance 
(high variability in mean TI of pristine Q1). Based on 
highest quenching efficiencies, subsequent experiments 
were performed with 0.5% PTMO and 0.2% SIVO160. 
The toxicity-reducing potential of the organosilane 
coatings was proven with 0.5% PTMO-coated quartz 
DQ12. As observed for Q1, a 0.5% PTMO coating 
significantly inhibited (by 97%) both the strong DQ12-
induced increase in LDH release and induction of direct 
DNA damage (Fig. 3).
In vitro determination of coating stability
Coating stability was investigated in vitro by incubat-
ing pristine/uncoated and 0.5% PTMO-coated Q1 in 
AAF or ALF for up to 168 h at 37°C. DNA damage, as 
the most sensitive endpoint, was used as readout. Pris-
tine Q1, incubated in AAF, significantly induced DNA 
damage, however, reduction in activity was noted with 
time (mean TI fresh Q1: 4.8 ± 0.7% and after 168 h: 
1.8 ± 0.8%). After 0, 24, and 48 h of incubation in 
AAF, 0.5% PTMO-coated Q1 induced significantly less 
DNA damage than uncoated Q1. After 72 and 168 h 
quenching of genotoxicity was still obvious, but did 
not reach statistical significance. All mean TI values for 
coated Q1 were within or slightly above the range for 
the particulate negative control Al2O3, indicating good 
coating stability at pH 7.4 (Fig. 4A). After incubation in 
ALF (pH 4.5), pristine Q1 predominantly demonstrated 
mean TIs like fresh Q1 (Fig. 4B). Mean TI was maxi-
mal after 168 h of incubation (4.8 ± 1.7%), compared to 
0.5 ± 0.1% for Al2O3. At all incubation times, the DNA-
damaging potential of 0.5% PTMO-coated Q1 was 
Figure 2. In vitro determination of coating effectiveness. AM were incubated ± 100 μM AL for 4 h with 75 μg cm−2 of uncoated 
Q1 or Q1, coated with different amounts of hydrolysed PTMO (A and B) or SIVO160 (C and D), Al2O3 as particulate negative (PNC) 
or DQ12 as quartz positive control. LDH release (A and C) and the alkaline comet assay (B and D) were used to detect membrane 
and direct DNA damage, respectively. Data represent means ± SD of three independent experiments. */**/***Significantly differ-
ent from PNC: P ≤ 0.05/0.01/0.001, respectively, Student’s t-test for unpaired values, two tailed. °/°°/°°°Significantly different from 
uncoated Q1: P ≤ 0.05/0.01/0.001, respectively, Student’s t-test for paired values, two tailed.
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significantly lower than that observed for uncoated Q1, 
however, with a tendency towards slightly higher mean 
TIs with time. Nevertheless, good quenching potential 
and appropriate coating stability was also demonstrated 
for PTMO at slightly acid conditions.
In vivo determination of coating efficiency and 
stability
To estimate in vivo coating efficiency and stability of the 
organosilane-based surface coatings, biological activity 
of pristine and 0.5% PTMO or 0.2% SIVO160-coated 
Q1 was investigated in rat lungs after intratracheal 
instillation (3-month post-treatment period). To avoid 
unspecific overload effects, a relatively low dose (1 mg 
dust lung−1) was selected. There were no effects on 
body weights in quartz-instilled rats (data not shown), 
but mean relative lung wet weights of DQ12-treated 
[5.9 ± 0.66 g kg−1 body weight (b.w.); P ≤ 0.01] and 
Q1-treated animals (5.2 ± 0.94 g kg−1 b.w.; not statisti-
cally significant) were increased 90-day post-treatment, 
compared to saline-treated controls (4.2 ± 0.83 g kg−1 
b.w.). Animals exposed to 0.5% PTMO-coated Q1 
Figure 3. In vitro determination of coating effectiveness using the quartz positive control DQ12. AM were incubated ± 100 μM 
aluminium lactate for 4 h with 75 μg cm−2 of uncoated quartz DQ12 or DQ12, coated with 0.5% hydrolysed PTMO (w/w quartz), 
culture medium as negative (NC), or Al2O3 as particulate negative control (PNC). LDH release (A) and the alkaline comet assay (B) 
were used to detect membrane and direct DNA damage, respectively. Data represent means ± SD of three independent experi-
ments. */***Significantly different from PNC: P ≤ 0.05/0.001, respectively, Student’s t-test for unpaired values, two tailed. °/°°Sig-
nificantly different from the uncoated DQ12 sample: P ≤ 0.05/0.01, Student’s t-test for paired values, two tailed.
Figure 4. In vitro determination of coating stability using the alkaline comet assay. Pristine Q1 and Q1 coated with 0.5% hydro-
lysed PTMO (w/w quartz) were incubated for 0, 24, 48, 72, or 168 h in (A) AAF or (B) ALF and were subsequently washed three 
times and finally freeze-dried. Primary rat alveolar macrophages were then incubated for 4 h at 37°C with the different quartz 
samples or culture medium as negative (NC), Al2O3 as particulate negative (PNC), and DQ12 as quartz positive control, using a 
concentration of 75 μg cm−2 and subjected to alkaline comet assay analyses. Data represent means ± SD of three independent 
experiments. */**/*** Significantly different from Al2O3: P ≤ 0.05/0.01/0.001, respectively, Student’s t-test for unpaired values, two 
tailed. °/°°Significantly different from uncoated Q1: P ≤ 0.05/0.01, respectively, Student’s t-test for paired values, two tailed.
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showed only slightly lower mean relative lung wet 
weight (4.8 ± 0.59 g kg−1 b.w.; no statistical significance) 
than Q1-treated animals, whereas mean relative lung wet 
weight of SIVO160-treated animals was clearly reduced 
to almost control level (4.3 ± 0.53 g kg−1 b.w.; no sta-
tistically significant difference to saline-treated animals), 
but without reaching statistical significance with regard 
to the Q1-treated group.
When evaluating biochemical endpoints in BAL 
fluid (Table 1A), DQ12 and uncoated Q1 showed the 
well-known latency period before full display of quartz 
effects (group mean values on day 90 post-instillation 
> day 28 post-treatment). Ninety-day post-instillation, 
pristine Q1 induced 4.2-, 3.8-, and 3.1-fold higher 
LDH release, β-glucuronidase activity, and total pro-
tein, respectively, compared to saline-treated controls. 
DQ12 was even more potent (11.0-, 18.9-, and 3.8-fold 
increases). Protective effects of the 0.5% PTMO and 
0.2% SIVO160 coatings were clearly evident 28-day 
post-instillation and were strongly more pronounced 
for SIVO160. SIVO160 significantly inhibited the 
Q1-induced increase in LDH release, β-glucuronidase 
activity, and total protein by 94, 86, and 100%, respec-
tively. Irrespective of its very promising in vitro effects, 
PTMO only slightly reduced Q1-induced LDH release 
(26%) and increase in total protein (49%). On day 90 
post-instillation, significant reduction in Q1-mediated 
biochemical effects was still evident for SIVO160 (LDH 
activity: −56%; β-glucuronidase activity: −79%; total 
protein: −69%). The 0.5% PTMO coating displayed 
only slight, non-significant inhibition (total protein: 
−28%).
On days 28 and 90 post-instillation (Table 1B), 
DQ12 mediated the strongest increase in total leukocytes 
and PMNs, followed by Q1 (total leukocytes: 2.4-fold 
induction 28- and 90-day post-instillation; PMNs: 85.0- 
and 49.5-fold increase on days 28 and 90, respectively). 
Additionally, a 16.6-fold (day 90 post-instillation) higher 
mean lymphocyte count was noted, compared to saline-
treated controls. At day 28 post-instillation, the 0.2% 
SIVO160 coating offered high protection with complete/
nearly complete inhibition of Q1-mediated increase in 
mean leukocyte number (100%) and PMNs (98%). The 
0.5% PTMO coating was slightly less effective with 78 
and 80% reduction, respectively. On day 90 post-instil-
lation, PTMO nearly lost its protective effect, as indi-
cated by only 10, 28, and 34% inhibition of Q1-induced 
increase in total leukocytes, PMNs, and lymphocytes. In 
contrast, SIVO160 still markedly protected lung tissue, 
with 75% (total leukocytes), 72% (PMNs), and 84% 
(lymphocyte number) reduction in Q1-mediated increase 
in cell counts.
In vitro determination of coating efficiency—
industrial scale
Due to promising performance of the 0.2% SIVO160 
coating in the in vivo 90-day study, the coating step 
was upscaled for a corresponding production plant, 
again with Q1 as model quartz. Coating efficiency was 
subsequently tested in vitro. Also under industrial scale 
conditions, coating with SIVO160 significantly inhibited 
Q1-mediated LDH release and DNA damage by 84 and 
80%, respectively (Fig. 5), without compromising prod-
uct quality due to integration of the SIVO160-based 
coating step into the ceramics’ production line (Escrig 
et al., 2014).
Discussion
Most likely due to limited in vivo coating stability and/
or a reduced availability of already lung-resident quartz 
particles for curative post-exposure coating, neither 
PVPNO nor aluminium salts brought a real break-
through in quartz passivation from the preventive and 
more importantly curative point of view (Weller, 1975; 
Zhao et al., 1983; Prügger et al., 1984; Goldstein and 
Rendall, 1987; Bégin et al., 1993; Dufresne et al., 1994; 
Bégin et al., 1995), raising the need for more promis-
ing preventive quartz-coating strategies for industries 
with potentially hazardous quartz exposure. In contrast 
to AL and PVPNO, exhibiting mechanisms based on 
ionic forces and hydrogen bonding, respectively (Fubini, 
1998a, 1998b; Albrecht, et al., 2007), organosilane com-
pounds, with their hydrolysed products organosilanols 
and organosiloxanes, are able to react covalently with 
quartz surface silanol groups (Wiessner et al., 1990), 
envisaging potentially more stable quartz coatings.
Indeed, as shown here, particularly the oligomeric, 
amino-modified siloxane SIVO160 seemed to possess 
considerable quartz toxicity-quenching potential and 
sufficient coating stability and/or potential to enhance 
quartz clearance from lungs over time. In 1986, Mor-
rison et al. investigated the protective potential of a 
hydrophobic organosilane layer to reduce cytotoxicity of 
chrysotile asbestos. However, using human pulmonary 
AM as in vitro model, organosilane-mediated decrease 
in mortality was only observed in the presence of dipal-
mitoyl lecithin. Later, Wiessner et al. (1990) studied 
the influence of certain organosilane-based coatings on 
pro-inflammatory and pro-fibrotic effects of α-quartz 
in the mouse lung after intratracheal injection, address-
ing well-defined surface charges [i.e. –N(CH3)3 and 
–NH2 (positive) versus –CH3 (neutral)]. Aiming to cor-
relate crystal surface structure characteristics with bio-
logical activity, they observed that pulmonary effects of 
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pristine α-quartz were quenched by organosilane surface 
coatings. Thereby, an –N(CH3)3 containing organosilane 
was less effective than organosilanes with –CH3 (hydro-
phobic) and –NH2 groups (hydrophilic). Therefore, the 
authors concluded that electrostatic rather than hydro-
gen bonding interactions may be primarily responsible 
for the biological activity of quartz surfaces. But, they 
did not envisage organosilane-based coatings as a poten-
tial preventive approach in industrial settings. First 
hints towards industrial usage came from Vallyathan 
et al. (1991). They used fresh quartz, coated with the 
organosilane Prosil 28 (CAS no. 81138-65-0), to inves-
tigate effects of fresh versus aged quartz on viability and 
activity of AM in vitro. They convincingly demonstrated 
a protective effect of Prosil 28, i.e. inhibition of quartz 
cytotoxicity, hydroxyl radical formation, and, addition-
ally, red blood cell haemolysis, an endpoint which seems 
to be directly correlated with quartz inflammogenicity 
(Pavan et al., 2014). The authors hence contemplated to 
use organosilanes in water sprays of drill bits to reduce 
quartz hazard in a specific occupational setting. Never-
theless, to our knowledge, organosilane-based coatings 
to date have not found their way into practical use as 
preventive agents in quartz-handling industries. Thus, 
the present study is setting the stage for a new field in 
occupational hygiene.
After intense physico-chemical characterization of 
several different organosilane-based coatings and speci-
fication of appropriate coating procedures, efficient and 
concentration-dependent inhibition of Q1-mediated 
adverse effects by organosilane coatings could be dem-
onstrated in vitro, using the commercially available 
compounds PTMO and SIVO160. This was in line with 
previous studies (Wiessner et al., 1990; Vallyathan et al., 
1991) and further supported the hypothesis of Wiessner 
et al. (1990) that electrostatic interactions might be piv-
otal to the biologic activity of quartz surfaces. SIVO160, 
which clearly inhibited adverse effects of Q1, effectively 
modified the negative, biologically active surface charge 
of Q1 to net-positivity. An isoelectric or even positive 
surface charge is thereby supposed to minimize adverse 
interactions between quartz surfaces and cell mem-
branes.
In the present study, it was possible to passivate 
both Q1 and DQ12 by the same organosilane-treat-
ment regime, indicating that the developed coating 
procedures might be universal tools for efficient quartz 
hazard reduction in the traditional ceramics industry. 
Nevertheless, the organosilane-to-quartz ratio seemed to 
be of utmost importance, particularly for SIVO160, as 
the highest SIVO160 concentration tested (1% w/w of 
quartz), in contrast to lower ones, was nearly inactive in 
quenching Q1-mediated effects in vitro. SIVO160 repre-
sents a pre-hydrolysed, waterborne silane system. As an 
oligomeric, amino-modified siloxane it possesses highly 
reactive but stabilized (at low pH) silanol groups. These 
can react with both silanol groups on the quartz surface, 
but also with other SIVO160 molecules in a condensa-
tion reaction at relatively low curing temperatures, form-
ing a dense network/layer (Evonik, 2009; Mack et al., 
2012). It can be speculated that in the environment used, 
and at higher concentrations, a shift towards condensa-
tion and high cross-linking activity may have occurred 
between the reactive silanol groups and the functional 
amino groups of the silane system. This may in turn have 
led to aggregate formation (personal communication: 
Figure 5. In vitro determination of coating effectiveness using Q1 under industrial scale conditions. AM were incubated ± 100 μM 
aluminium lactate for 4 h with 75 μg cm−2 of pristine Q1 or Q1 coated with 0.2% (w/w quartz) SIVO160, Al2O3 as particulate nega-
tive (PNC), or DQ12 as quartz positive control. Culture medium only served as negative control (NC). LDH release (A) and the alka-
line comet assay (B) were used to detect membrane and direct DNA damage, respectively. Data represent means ± SD of three 
independent experiments. */**/***Significantly different from PNC: P ≤ 0.05/0.01/0.001, respectively, Student’s t-test for unpaired 
values, two tailed. °Significantly different from pristine Q1: P ≤ 0.05, Student’s t-test for paired values, two tailed.
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Dr. Burkard Standke, Degussa International AG, Essen, 
Germany) and hindrance of the quartz-coating reac-
tion. However, it cannot be excluded either that a pro-
foundly altered quartz surface charge may also have 
been responsible for loss in protective potential at higher 
concentrations.
After promising in vitro results, a confirmatory 
in vivo experiment in rats was performed with 0.5% 
PTMO- and 0.2% SIVO160-coated Q1. A study design 
with a 90-day post-treatment observation period was 
selected to enable evaluation of both coating efficiency 
and constancy of the surface-protective properties. 
A protective effect could be demonstrated in rat lungs 
for both PTMO and SIVO160 on day 28 post-treatment, 
with markedly higher efficiency for SIVO160. The abso-
lute number of cells was more informative here than 
relative cell counts. For SIVO160 a marked quartz-
quenching effect was still detected 90-day post-treat-
ment, when PTMO had unexpectedly lost its protective 
properties, indicating a limited potential of the in vitro 
test to really predict in vivo long-term tissue reactions.
Marked loss in protective activity of PTMO might be 
based on slow, time-dependent destruction of the PTMO 
surface coating. Interestingly, Albrecht et al. (2004) pre-
sumed partial, mechanistically unclear removal of also 
PVPNO coating over time in vivo, as having observed 
that a considerable lung-protective effect of PVPNO at 
least partially persisted over 90 days, however with some 
adverse effects reappearing at later time points (180- and 
360-day post-instillation). As an approach to go more 
profoundly into conceivable mechanistic details, PTMO 
coating can be chemically understood as being covalent. 
An explanation for progressive bondage loss could be a 
partial disintegration of the particles’ mineral surface 
under the conditions of lung fluid ambience, i.e. mechani-
cally small debris may be formed or it is simply a disso-
lution effect by water reaching the surface of the coated 
quartz particles. Additionally, one can hypothesize that 
lysosomal enzymes may cause partial removal of coating 
material with time, as discussed for delayed lung reactivity 
of some quartz species through delayed removal of Al2O3 
surface contaminations (Adamis et al., 2000). This might, 
at least in part, explain the obviously higher PTMO coat-
ing stability in vitro because the acellular AAF incubation 
approach lacked enzyme activities. Reduced stability of 
PTMO coating in vivo might also be based on avoidance 
of a high-temperature curing step at 100–200°C to pre-
clude disturbance of the production process and nega-
tive impact on product quality by early integration of the 
coating step into the ceramics production lines. Such a 
curing step is, however, important for a standard silane 
system like PTMO to favour condensation. Without an 
adequate curing step, coating defects and back reactions 
can occur (B. Standke, Degussa International AG, Essen, 
Germany, personal communication).
In the lung environment, the markedly higher protec-
tive effect of SIVO160, compared to PTMO, may also 
be caused by different chemistry and a different steric 
outcome of the coating reaction. While PTMO forms 
rather ‘hedgehog-like’ coatings, the molecular weight of 
the SIVO160 molecule has been tailored for optimized 
wetting behaviour and cross-linking activities, leading 
to formation of homogeneous cross-linked surface lay-
ers (ideally monomolecular films) on substrates. Due 
to optimized wetting properties, high reactivity, and 
high cross-linking activity/density through amino func-
tional groups of SIVO160, water penetration through 
the resulting tight coating layer is prevented, leading to 
unavailability of potentially free quartz surface silanol 
groups. Furthermore, SIVO160, in contrast to PTMO, 
does not need a curing step to build up a tight inorganic–
organic network without defects and thereby effectively 
modifies the quartz surface charge by rendering the sur-
face isoelectric or even positive, with subsequent blunt-
ing of biological activity.
Comparable particle size distributions suggest no 
impact of particle size on observed differences seen in 
coating efficiency and perhaps stability of SIVO160 and 
PTMO in vivo, but a role of differential modification of 
particle uptake and clearance cannot be ruled out. Albrecht 
et al. (2007) showed that quartz coating with PVPNO or 
AL resulted in reduced particle lung burden 90-day post-
instillation in rats, compared to pristine quartz. They 
found lower lung burden with PVPNO-treated quartz 
than with AL-treated quartz, perhaps due to better and 
earlier uptake of PVPNO-coated quartz particles com-
pared to AL-coated quartz particles by AM, as observed 
in vitro. These authors concluded that the surface proper-
ties of quartz particles are crucial for their uptake by AM, 
thus dictating their clearance kinetics. As SIVO160-coated 
quartz particles exhibited a clearly stronger protective 
effect in vivo, compared to the PTMO-coated particles, 
with differential surface charges and properties of the two 
materials, it might be hypothesized that the SIVO160 coat-
ing perhaps better favoured particle clearance than the 
PTMO coating. To confirm this working hypothesis, it 
would be crucial to determine particle lung burdens and 
the resulting clearance half-times for differentially coated 
quartz species in future experiments.
Conclusions
As a progress in industrial hygiene, quartz-induced 
adverse lung effects in coal industry workers were 
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previously cured by inhalation of protective coating 
agents (Holt, 1985), used as retroactive risk manage-
ment tool. In contrary, in the present study, a proactive 
approach was designed to mitigate quartz toxicity at the 
beginning of the ceramics production flow. The obtained 
results show strong evidence for covalent organosilane-
based quartz surface coatings being a promising pro-
tection strategy to reduce quartz-specific toxicity in the 
traditional ceramics industry, at least for short- and 
mid-term periods after occupational exposure. However, 
considering the human lung with clearance half-times of 
~1 year for lung-deposited dusts, further optimization 
should be pursued, aiming at an in vivo stability period in 
the lung of >1 year. Furthermore, it should be evaluated 
whether integration of the coating step into ceramics pro-
duction processes or working with already organosilane-
coated quartz raw materials in the production line would 
provide better and more effective workers’ protection.
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